Loading...

United Therapeutics Corporation

UTHR•NASDAQ
Healthcare
Biotechnology
$567.16
$-5.69(-0.99%)
U.S. Market opens in 49h 27m

United Therapeutics Corporation (UTHR) Stock Overview

Explore United Therapeutics Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap24.9B
P/E Ratio18.79
EPS (TTM)$27.88
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$512.85
3 Months$429.99
1 Year Target$457.60

UTHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of United Therapeutics Corporation (UTHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $457.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.79 and a market capitalization of 24.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.99%
5-Day Change
-2.02%
1-Month Change
6.65%
3-Month Change
20.95%
6-Month Change
35.50%
Year-to-Date (YTD) Change
16.40%
1-Year Change
91.34%
3-Year Change
148.44%
5-Year Change
172.53%
All-Time (Max) Change
9207.24%

Contact Information

https://www.unither.com
301 608 9292
1040 Spring Street, Silver Spring, MD, 20910

Company Facts

1,305 Employees
IPO DateJun 17, 1999
CountryUS
Actively Trading

Frequently Asked Questions